Pasithea Therapeutics Corp. - Common Stock — États financiers (NASDAQ:KTTA) | MetaTrader

Afficher le graphique complet Full chart

Nouvelles

Pasithea Therapeutics Corp. (KTTA) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transcript

Pasithea provides updates on clinical trials for MEK inhibitor drug

Pasithea Therapeutics retrouve la conformité au Nasdaq concernant le prix minimum d’offre

Pasithea Therapeutics regains Nasdaq compliance with minimum bid price rule

Pasithea Therapeutics : début de couverture avec recommandation d’achat par H.C. Wainwright

Pasithea Therapeutics stock initiated with Buy rating at H.C. Wainwright

Pourquoi les actions de Vision Marine Technologies sont en hausse de plus de 10 %; Voici 20 actions qui bougent avant l'ouverture du marché | Benzinga France

Why Vision Marine Technologies Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - CEA Industries (NASDAQ:BNC), Aditxt (NASDAQ:ADTX)

Pourquoi les actions de Heartbeam se négocient-elles en hausse d'environ 43% ? Voici 20 actions qui bougent avant l'ouverture du marché | Benzinga France

Crude Oil Gains 1%; Tilray Brands Shares Plunge - Rich Sparkle Holdings (NASDAQ:ANPA), HeartBeam (NASDAQ:BEAT)

Why Heartbeam Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket - Anglogold Ashanti (NYSE:AU), HeartBeam (NASDAQ:BEAT)

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.67%